Breast Implant Market Size (2024 - 2029)

Breast Implant Market Analysis

The Breast Implant Market size is estimated at USD 2.05 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).

Breast implants are becoming more popular in emerging and developing countries as women become more aware of body image and seek to enhance their appearance. A study published in August 2023 by the National Library of Medicine found that breast augmentation can have a positive impact on the sexual function of women with hypomania. Along with that, the growing desire among women for beauty-enhancing breast augmentation and reconstruction procedures is expected to contribute to the growth of the breast implant market.

According to the International Society for Aesthetic Plastic Surgeons (ISAPS), approximately 2.2 million breast augmentation procedures were reported globally in 2022, representing a significant 29% increase compared to the procedures reported in 2021. This surge in procedures is expected to drive demand for breast implants, thereby boosting the breast implants market.

The global rise in breast cancer cases is also a significant factor influencing market growth, leading to increased demand in the breast prosthesis market. According to GLOBOCAN 2022, 11.5% of the total cancers accounted for breast cancer, marking it as the third most common cancer type. The Australian Institute of Health and Welfare's 2024 report projected approximately 20,500 new cases of breast cancer in females for 2023, representing 28% of all female cancer diagnoses. In Australia, breast cancer ranks as the second most prevalent cancer among individuals aged 20 to 39 and 60 to 79 and as the leading cancer for those aged 40 to 59. The increasing number of breast cancers is likely to boost the requirement for breast implantation, including in the breast prosthesis implant market, resulting in market growth over the forecast period.

Breast implant companies are consistently trying to develop better and more efficient solutions in order to extend the lifespan of existing products. This is being achieved through strategic initiatives like awareness campaigns about breast implants, product launches, collaborations, and mergers and acquisitions.

For example, in January 2024, CollPlant Biotechnologies initiated a pre-clinical trial aimed at evaluating commercial-sized, regenerative, 3D-bioprinted breast implants. According to the company, as of January 2024, no commercial products allow the regeneration of soft tissues, including breast tissue. The main objective of this trial is to collect data to support the optimization of implant design. The refined design is expected to be used in a pivotal study intended for discussions with the United States FDA. The development of advanced breast implants is expected to significantly contribute to the market's expansion.

Factors such as the increasing incidence of breast cancer and the proactive initiatives taken by companies in product development are projected to play a key role in driving the breast implant market growth throughout the forecast period. However, there are also notable obstacles to the market's growth, such as post-surgery complications, associated risks, and the significant cost involved.

Breast Implant Industry Segmentation

As per the scope of this report, breast implants are medical devices used to augment the size of breasts, either for cosmetic applications or reconstruction purposes or to correct a congenital abnormality. The procedure involves the usage of breast implants to enhance and improve the size of the breasts.

The market is segmented by type, application, end user, and geography. By type, the market is segmented by silicone implants, form-stable implants, saline implants, and structured saline implants. By application, the market is segmented by reconstructive surgery and cosmetic surgery. By end user, the market is segmented into hospitals, cosmetology clinics, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the market size and forecasts for the breast implants market in 17 countries across the major regions. The report offers the value (USD) for the above segments.